|
|
| Countries covered: China China Pharmaceutical & Biotechnology Monthly is the intelligent guide to China’s healthcare industry. Filled with news, analysis, and coverage of the financial markets, CPB Monthly is essential for professionals and managers serious about tracking the opportunities and challenges China presents. Its contents include top stories, key facts and figures, news in general, policy and regulations, investments and finance, company, trade, research & development and IP & legal. It also has two company profiles and equity market review. What do I get with a subscription? • You get a PDF file monthly newsletter with all the news from the month, lead articles, and capital markets overview • You get access to the news briefs headlines and full articles daily as they are created on www.gbipharma.com • You get a weekly email that includes the headlines and links to the articles • You get access to any pod casts or interviews GB conducts |
More China Research & Development Reports
Chinese Markets for Hepatitis Drugs by
Asia Market Information & Development Company
China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ...
Research Report on Chinese Bio-pharmaceutical Industry, 2012 by
China Research and Intelligence Co., Ltd.
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). ...
Research Report on Chinese Human Vaccine Industry, 2012 by
China Research and Intelligence Co., Ltd.
The research object of the report is human vaccine apart from animal vaccine. Vaccination is the most economical, effective, safe and convenient way to prevent ...
China Pharmaceutical Industry Research and Forecast to 2016 by
AM Mindpower Solutions
EXECUTIVE SUMMARY The present report on “China Pharmaceutical Industry Research and Forecast to 2016” analyzes in detail the pharmaceutical industry environment with market sizing in terms ...
China Pharma Outsourcing Annual Review 2011 by
JZMed, Inc.
In our 2010 China Pharma Outsourcing Annual Review, we analyzed and forecasted the possible development trends of the Chinese pharma outsourcing market in 2011. After ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Juice – China – a snapshot (2010) by
Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...
See all reports like this >>
Related Markets
- Biotechnology
- General Biotechnology
- Research & Development
- Facilities
- Hospitals & Clinics
- Life Sciences
- Pharmaceuticals
- Pharmaceuticals
- Research & Development
Research & Development Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
- Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
- Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion
- Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
